Back to Search Start Over

Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies

Authors :
Maryam Ali Al-Nesf
Hamda Qotba
Ali Ait Hssain
Farah Shurrab
Sara Taleb
Gheyath K. Nasrallah
Hashim Alhussain
Soha R. Dargham
Hadi M. Yassine
Salma Younes
Abdullatif Al-Khal
Laith J. Abu-Raddad
Patrick Tang
Duaa W. Al-Sadeq
Reham M. Marei
Hadeel Al-Jighefee
Asmaa Ali J. F. Althani
Source :
International Journal of Infectious Diseases, Vol 102, Iss, Pp 181-187 (2021), International Journal of Infectious Diseases
Publication Year :
2021
Publisher :
Elsevier, 2021.

Abstract

Highlights • Performances of five commercial ELISA (EDI, AnshLabs, Dia.Pro, NovaTec, and Lionex) for detecting anti-SARS-CoV-2 IgG was evaluated. • Samples used in this study are from diverse national background and the negative group contains samples that are seropositive for all other HCoV. • All assays showed low sensitivity during the early stages (≤7 from symptom onset); however, it was greatly improved overtime. • Lionex showed the highest specificity (98.6%), followed by EDI and Dia.Pro (97.1%,), NovaTec (85.7%), and AnshLabs (75.7%). • Lionex, which measures antibodies to the S1 protein, demonstrated the best performance and doesn’t cross-react with any other HCoV.<br />Objectives To evaluate and compare the performances of five commercial ELISA assays (EDI, AnshLabs, Dia.Pro, NovaTec, and Lionex) for detecting anti-SARS-CoV-2 IgG. Methods 70 negative control samples (collected before the COVID-19 pandemic) and samples from 101 RT-PCR-confirmed SARS-CoV-2 patients (collected at different time points from symptoms onset: ≤7, 8-14, and >14 days) were used to compare the sensitivity, specificity, agreement, positive and negative predictive values of each assay with RT-PCR. A concordance assessment between the five assays was also conducted. Cross-reactivity with other HCoV, non-HCoV respiratory viruses, non-respiratory viruses, and nuclear antigens was investigated. Results Lionex showed the highest specificity (98.6%, 95%CI: 92.3-99.8), followed by EDI and Dia.Pro (97.1%, 95%CI: 90.2-99.2), NovaTec (85.7%, 95%CI: 75.7-92.1), then AnshLabs (75.7%, 95%CI: 64.5-84.2). All ELISA kits cross-reacted with one anti-MERS IgG positive sample except Lionex. The sensitivity was low during the early stages of the disease but improved over time. After 14 days from symptoms onset, Lionex and NovaTec showed the highest sensitivity at 87.9% (95%CI: 72.7-95.2) and 86.4% (95%CI: 78.5-91.7), respectively. The agreement with RT-PCR results based on Cohen’s kappa was as follows: Lionex (0.89)> NovaTec (0.70)> Dia.Pro (0.69)> AnshLabs (0.63)> EDI (0.55). Conclusion The Lionex ELISA, which measures antibodies solely to the S1 protein, demonstrated the best performance.

Details

Language :
English
ISSN :
12019712
Volume :
102
Database :
OpenAIRE
Journal :
International Journal of Infectious Diseases
Accession number :
edsair.doi.dedup.....323f382b11794762c264ccaf1e00c8d3